Mothercare (MTC) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
29 Dec, 2025Executive summary
Worldwide retail sales by franchise partners fell 25% year-over-year to £90.7 million, mainly due to Middle East store closures and the planned exit from Boots.
Adjusted EBITDA dropped to £0.8 million from £1.7 million, with an adjusted loss from operations of £0.5 million versus a £1.1 million profit last year.
Net debt reduced significantly to £5.8 million from £17.1 million a year ago.
New partnerships in South Asia (Reliance) and Turkey (Ebebek) are expected to drive future growth.
Financial highlights
Revenue for the period was £11.6 million, down from £21.0 million year-over-year.
Gross profit was £5.0 million, down from £8.0 million.
Adjusted loss before taxation was £1.1 million, compared to a £1.4 million loss last year.
Basic and diluted loss per share was (0.3)p, unchanged from the prior year.
Net cash flow from operating activities was negative £0.7 million.
Outlook and guidance
Focus for 2026 is on rebuilding scale and operations in the UK and globally, and refinancing existing debt.
Forecasts show a generally cash-neutral position over the next 12 months, with growth expected in Turkey and India.
Directors intend to resume dividend payments when financially prudent.
Latest events from Mothercare
- Adjusted EBITDA grew to £6.9m as debt refinancing and a South Asia JV improved financial stability.MTC
H2 202424 Feb 2026 - Retail sales fell 18% to £230.6m, with profit boosted by a South Asia JV and debt reduction.MTC
H2 202524 Feb 2026 - Sales fell 18% amid Middle East headwinds, but net borrowings dropped and growth plans continue.MTC
Trading Update6 Jun 2025 - Profitability improved despite a 15% sales drop, with refinancing and cost control in focus.MTC
H1 20245 Jun 2025 - Retail sales declined, but profitability improved and refinancing efforts are in progress.MTC
Trading Update5 Jun 2025 - New South Asian JV and refinancing de-leverage Mothercare amid ongoing Middle East challenges.MTC
H1 20255 Jun 2025